methyl N-[(3beta,17beta-dihydroxy-5alpha-androstan-17alpha-yl)methyl]carbamate

ID: ALA4170304

PubChem CID: 145955597

Max Phase: Preclinical

Molecular Formula: C22H37NO4

Molecular Weight: 379.54

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)NC[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C

Standard InChI:  InChI=1S/C22H37NO4/c1-20-9-6-15(24)12-14(20)4-5-16-17(20)7-10-21(2)18(16)8-11-22(21,26)13-23-19(25)27-3/h14-18,24,26H,4-13H2,1-3H3,(H,23,25)/t14-,15-,16+,17-,18-,20-,21-,22+/m0/s1

Standard InChI Key:  LZIBFKUCRZFDCI-KRXHPCMFSA-N

Molfile:  

     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   27.5369   -2.5919    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.5410   -3.4091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2466   -2.9969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2074   -4.8660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2074   -5.6873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9168   -6.0959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9168   -4.4533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6221   -4.8660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6186   -5.6873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3248   -6.1008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0390   -5.6933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3318   -4.4581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0386   -4.8745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0553   -3.2356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3370   -3.6395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7621   -3.6561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7533   -4.4740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5286   -4.7339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0183   -4.0766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4962   -6.1011    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.6148   -4.0447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0304   -4.0529    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   26.7568   -2.8313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6107   -6.5045    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   25.3247   -5.2787    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   26.7486   -5.2952    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   28.9564   -3.4019    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.6620   -2.9898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3718   -3.3948    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.6579   -2.1726    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.3635   -1.7604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  2  3  1  0
  4  5  1  0
  4  7  1  0
  5  6  1  0
  6  9  1  0
  8  7  1  0
  8  9  1  0
  8 12  1  0
  9 10  1  0
 10 11  1  0
 11 13  1  0
 12 13  1  0
 12 15  1  0
 13 17  1  0
 16 14  1  0
 14 15  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19  2  1  0
  2 16  1  0
  5 20  1  1
  8 21  1  1
 13 22  1  1
 16 23  1  1
  9 24  1  6
 12 25  1  6
 17 26  1  6
  3 27  1  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4170304

    ---

Associated Targets(Human)

SW1573 (1008 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HBL-100 (746 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T47D (39041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
WiDr (1835 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 379.54Molecular Weight (Monoisotopic): 379.2723AlogP: 3.48#Rotatable Bonds: 2
Polar Surface Area: 78.79Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.92CX Basic pKa: CX LogP: 2.77CX LogD: 2.77
Aromatic Rings: Heavy Atoms: 27QED Weighted: 0.69Np Likeness Score: 1.79

References

1. Romero-Hernández LL, Merino-Montiel P, Meza-Reyes S, Vega-Baez JL, López Ó, Padrón JM, Montiel-Smith S..  (2018)  Synthesis of unprecedented steroidal spiro heterocycles as potential antiproliferative drugs.,  143  [PMID:29172080] [10.1016/j.ejmech.2017.10.063]

Source